http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016016774-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-10
filingDate 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5772d14c912e3ce481cfc0d20409821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ce8b2a5fadf89921d322a41b247b73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_738c883d4b57addf42adaf4853db7101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01ca1496b1b57cde4184e7a45886f7f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c3ce281ea8d80a0aae2a967fa9ec1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff4b5cb00153edf76dc499ed3a993d24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646ccea422ef5112d564fc9caf73b699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2296d7644c6db088553ec5f8bbe9e674
publicationDate 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016016774-A8
titleOfInvention Crystalline forms of canagliflozin
abstract The present invention relates to crystalline forms of canagliflozin, processes for their preparation, and their use for the treatment of type 2 diabetes mellitus. A crystalline Form R3 pf canagliflozin hyrate. The crystalline Form R-3 canagliflozin hydrate, characterized by an X-ray powder diffraction peaks having d-spacing values at about 9.2,4.1,4.5, and 7.2 Å.
priorityDate 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453324755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24997615

Total number of triples: 20.